US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 397.480
  • -0.220-0.06%
Close Apr 26 16:00 ET
  • 397.420
  • -0.060-0.02%
Post 18:01 ET
102.73BMarket Cap28.62P/E (TTM)

Vertex Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
4.08%11.22B
4.08%11.22B
22.08%11.93B
21.43%11.24B
26.41%10.41B
43.24%10.78B
43.24%10.78B
40.37%9.77B
37.95%9.25B
18.98%8.24B
-Cash and cash equivalents
-1.28%10.37B
-1.28%10.37B
21.14%11.11B
16.65%10.15B
22.23%9.29B
54.58%10.5B
54.58%10.5B
46.14%9.17B
43.51%8.7B
20.55%7.6B
-Short-term investments
209.36%849.2M
209.36%849.2M
36.52%818M
96.88%1.09B
76.21%1.12B
-62.39%274.5M
-62.39%274.5M
-12.55%599.2M
-14.45%551.2M
2.96%638M
Receivables
8.40%1.56B
8.40%1.56B
11.08%1.54B
16.75%1.56B
19.72%1.55B
26.86%1.44B
26.86%1.44B
25.88%1.39B
43.45%1.33B
32.25%1.29B
-Accounts receivable
8.40%1.56B
8.40%1.56B
11.08%1.54B
16.75%1.56B
19.72%1.55B
26.86%1.44B
26.86%1.44B
25.88%1.39B
43.45%1.33B
32.25%1.29B
Inventory
60.40%738.8M
60.40%738.8M
77.41%688.7M
64.13%603.5M
57.89%535.1M
30.44%460.6M
30.44%460.6M
16.42%388.2M
14.33%367.7M
13.40%338.9M
Prepaid assets
24.56%537.6M
24.56%537.6M
----
----
----
-2.38%431.6M
-2.38%431.6M
----
----
----
Other current assets
13.31%84.3M
13.31%84.3M
-25.68%540.2M
-13.21%476.9M
-4.64%468.7M
25.68%74.4M
25.68%74.4M
58.77%726.9M
10.17%549.5M
45.02%491.5M
Total current assets
6.87%14.14B
6.87%14.14B
19.76%14.7B
20.60%13.87B
25.14%12.97B
38.43%13.23B
38.43%13.23B
38.62%12.27B
36.02%11.5B
21.34%10.36B
Non current assets
Net PPE
-0.20%1.45B
-0.20%1.45B
-1.84%1.43B
2.00%1.45B
0.81%1.45B
2.20%1.46B
2.20%1.46B
7.88%1.46B
6.00%1.42B
9.78%1.44B
-Gross PPE
6.39%2.64B
6.39%2.64B
-1.84%1.43B
2.00%1.45B
0.81%1.45B
7.01%2.48B
7.01%2.48B
7.88%1.46B
6.00%1.42B
9.78%1.44B
-Accumulated depreciation
-15.73%-1.19B
-15.73%-1.19B
----
----
----
-14.65%-1.03B
-14.65%-1.03B
----
----
----
Goodwill and other intangible assets
13.97%1.93B
13.97%1.93B
0.76%1.69B
21.77%1.69B
20.64%1.69B
20.64%1.69B
20.64%1.69B
19.73%1.68B
-0.92%1.39B
0.00%1.4B
-Goodwill
0.00%1.09B
0.00%1.09B
1.19%1.09B
8.56%1.09B
8.56%1.09B
8.56%1.09B
8.56%1.09B
7.29%1.08B
0.00%1B
0.00%1B
-Other intangible assets
39.15%839.9M
39.15%839.9M
0.00%603.6M
55.97%603.6M
50.90%603.6M
50.90%603.6M
50.90%603.6M
50.90%603.6M
-3.25%387M
0.00%400M
Investments and advances
2,126.20%2.5B
2,126.20%2.5B
--1.7B
--1.36B
--1.08B
--112.2M
--112.2M
----
----
----
Non current deferred assets
45.33%1.81B
45.33%1.81B
48.71%1.73B
34.46%1.54B
43.83%1.36B
33.43%1.25B
33.43%1.25B
24.51%1.16B
20.05%1.14B
15.89%945.5M
Other non current assets
118.58%895.3M
118.58%895.3M
258.64%475.2M
247.76%442.7M
286.18%427.5M
269.68%409.6M
269.68%409.6M
75.45%132.5M
79.05%127.3M
124.72%110.7M
Total non current assets
74.65%8.59B
74.65%8.59B
58.51%7.03B
58.78%6.48B
54.27%6.01B
26.97%4.92B
26.97%4.92B
17.77%4.44B
8.36%4.08B
8.92%3.89B
Total assets
25.23%22.73B
25.23%22.73B
30.05%21.73B
30.59%20.35B
33.10%18.97B
35.13%18.15B
35.13%18.15B
32.39%16.71B
27.50%15.58B
17.67%14.26B
Liabilities
Current liabilities
Payables
9.31%702M
9.31%702M
196.22%375.9M
83.33%363M
86.18%323.2M
5.85%642.2M
5.85%642.2M
-0.75%126.9M
55.25%198M
35.80%173.6M
-accounts payable
20.07%364.9M
20.07%364.9M
196.22%375.9M
83.33%363M
86.18%323.2M
55.85%303.9M
55.85%303.9M
-0.75%126.9M
55.25%198M
35.80%173.6M
-Total tax payable
-19.30%99.5M
-19.30%99.5M
----
----
----
-41.65%123.3M
-41.65%123.3M
----
----
----
-Other payable
10.51%237.6M
10.51%237.6M
----
----
----
7.29%215M
7.29%215M
----
----
----
Current accrued expenses
29.62%2.32B
29.62%2.32B
28.39%2.91B
22.58%2.6B
35.19%2.33B
41.16%1.79B
41.16%1.79B
42.87%2.26B
42.96%2.12B
12.30%1.72B
Current debt and capital lease obligation
-6.38%83.7M
-6.38%83.7M
----
----
----
11.47%89.4M
11.47%89.4M
----
----
----
-Current capital lease obligation
-6.38%83.7M
-6.38%83.7M
----
----
----
11.47%89.4M
11.47%89.4M
----
----
----
Current deferred liabilities
6.70%170.3M
6.70%170.3M
----
----
----
-7.05%159.6M
-7.05%159.6M
----
----
----
Other current liabilities
337.12%273.2M
337.12%273.2M
45.05%316.2M
63.80%391M
31.77%377M
278.79%62.5M
278.79%62.5M
8.24%218M
5.45%238.7M
0.68%286.1M
Current liabilities
29.37%3.55B
29.37%3.55B
37.95%3.6B
31.14%3.35B
38.80%3.03B
28.02%2.74B
28.02%2.74B
36.31%2.61B
39.19%2.56B
12.15%2.18B
Non current liabilities
Long term debt and capital lease obligation
-10.56%724.7M
-10.56%724.7M
-9.69%744.7M
-9.41%767.6M
-9.55%789.2M
-8.67%810.3M
-8.67%810.3M
-5.95%824.6M
-5.21%847.3M
-2.93%872.5M
-Long term capital lease obligation
-10.56%724.7M
-10.56%724.7M
-9.69%744.7M
-9.41%767.6M
-9.55%789.2M
-8.67%810.3M
-8.67%810.3M
-5.95%824.6M
-5.21%847.3M
-2.93%872.5M
Other non current liabilities
-15.75%196.3M
-15.75%196.3M
257.88%869.3M
209.67%759.3M
145.11%726.5M
-23.18%233M
-23.18%233M
-18.21%242.9M
-16.88%245.2M
1.52%296.4M
Total non current liabilities
7.11%1.6B
7.11%1.6B
51.19%1.61B
39.76%1.53B
29.67%1.52B
25.67%1.5B
25.67%1.5B
-9.05%1.07B
-8.10%1.09B
-1.84%1.17B
Total liabilities
21.51%5.15B
21.51%5.15B
41.79%5.21B
33.72%4.88B
35.62%4.54B
27.18%4.24B
27.18%4.24B
19.07%3.68B
20.61%3.65B
6.84%3.35B
Shareholders'equity
Share capital
0.00%2.6M
0.00%2.6M
0.00%2.6M
0.00%2.6M
0.00%2.6M
4.00%2.6M
4.00%2.6M
1.48%2.6M
0.35%2.6M
0.46%2.6M
-common stock
0.00%2.6M
0.00%2.6M
0.00%2.6M
0.00%2.6M
0.00%2.6M
4.00%2.6M
4.00%2.6M
1.48%2.6M
0.35%2.6M
0.46%2.6M
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
55.49%10.14B
55.49%10.14B
60.83%9.17B
70.49%8.14B
82.26%7.22B
103.79%6.52B
103.79%6.52B
134.66%5.7B
202.36%4.77B
162.13%3.96B
Paid-in capital
0.86%7.45B
0.86%7.45B
1.58%7.34B
3.79%7.37B
4.18%7.22B
7.35%7.39B
7.35%7.39B
1.97%7.23B
-7.07%7.1B
-7.59%6.93B
Gains losses not affecting retained earnings
-1,887.50%-14.3M
-1,887.50%-14.3M
-103.07%-3M
-169.22%-39.8M
-215.93%-13.1M
-94.97%800K
-94.97%800K
745.97%97.6M
328.55%57.5M
133.93%11.3M
Total stockholders'equity
26.36%17.58B
26.36%17.58B
26.73%16.51B
29.64%15.47B
32.32%14.43B
37.75%13.91B
37.75%13.91B
36.71%13.03B
29.76%11.93B
21.46%10.91B
Total equity
26.36%17.58B
26.36%17.58B
26.73%16.51B
29.64%15.47B
32.32%14.43B
37.75%13.91B
37.75%13.91B
36.71%13.03B
29.76%11.93B
21.46%10.91B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 4.08%11.22B4.08%11.22B22.08%11.93B21.43%11.24B26.41%10.41B43.24%10.78B43.24%10.78B40.37%9.77B37.95%9.25B18.98%8.24B
-Cash and cash equivalents -1.28%10.37B-1.28%10.37B21.14%11.11B16.65%10.15B22.23%9.29B54.58%10.5B54.58%10.5B46.14%9.17B43.51%8.7B20.55%7.6B
-Short-term investments 209.36%849.2M209.36%849.2M36.52%818M96.88%1.09B76.21%1.12B-62.39%274.5M-62.39%274.5M-12.55%599.2M-14.45%551.2M2.96%638M
Receivables 8.40%1.56B8.40%1.56B11.08%1.54B16.75%1.56B19.72%1.55B26.86%1.44B26.86%1.44B25.88%1.39B43.45%1.33B32.25%1.29B
-Accounts receivable 8.40%1.56B8.40%1.56B11.08%1.54B16.75%1.56B19.72%1.55B26.86%1.44B26.86%1.44B25.88%1.39B43.45%1.33B32.25%1.29B
Inventory 60.40%738.8M60.40%738.8M77.41%688.7M64.13%603.5M57.89%535.1M30.44%460.6M30.44%460.6M16.42%388.2M14.33%367.7M13.40%338.9M
Prepaid assets 24.56%537.6M24.56%537.6M-------------2.38%431.6M-2.38%431.6M------------
Other current assets 13.31%84.3M13.31%84.3M-25.68%540.2M-13.21%476.9M-4.64%468.7M25.68%74.4M25.68%74.4M58.77%726.9M10.17%549.5M45.02%491.5M
Total current assets 6.87%14.14B6.87%14.14B19.76%14.7B20.60%13.87B25.14%12.97B38.43%13.23B38.43%13.23B38.62%12.27B36.02%11.5B21.34%10.36B
Non current assets
Net PPE -0.20%1.45B-0.20%1.45B-1.84%1.43B2.00%1.45B0.81%1.45B2.20%1.46B2.20%1.46B7.88%1.46B6.00%1.42B9.78%1.44B
-Gross PPE 6.39%2.64B6.39%2.64B-1.84%1.43B2.00%1.45B0.81%1.45B7.01%2.48B7.01%2.48B7.88%1.46B6.00%1.42B9.78%1.44B
-Accumulated depreciation -15.73%-1.19B-15.73%-1.19B-------------14.65%-1.03B-14.65%-1.03B------------
Goodwill and other intangible assets 13.97%1.93B13.97%1.93B0.76%1.69B21.77%1.69B20.64%1.69B20.64%1.69B20.64%1.69B19.73%1.68B-0.92%1.39B0.00%1.4B
-Goodwill 0.00%1.09B0.00%1.09B1.19%1.09B8.56%1.09B8.56%1.09B8.56%1.09B8.56%1.09B7.29%1.08B0.00%1B0.00%1B
-Other intangible assets 39.15%839.9M39.15%839.9M0.00%603.6M55.97%603.6M50.90%603.6M50.90%603.6M50.90%603.6M50.90%603.6M-3.25%387M0.00%400M
Investments and advances 2,126.20%2.5B2,126.20%2.5B--1.7B--1.36B--1.08B--112.2M--112.2M------------
Non current deferred assets 45.33%1.81B45.33%1.81B48.71%1.73B34.46%1.54B43.83%1.36B33.43%1.25B33.43%1.25B24.51%1.16B20.05%1.14B15.89%945.5M
Other non current assets 118.58%895.3M118.58%895.3M258.64%475.2M247.76%442.7M286.18%427.5M269.68%409.6M269.68%409.6M75.45%132.5M79.05%127.3M124.72%110.7M
Total non current assets 74.65%8.59B74.65%8.59B58.51%7.03B58.78%6.48B54.27%6.01B26.97%4.92B26.97%4.92B17.77%4.44B8.36%4.08B8.92%3.89B
Total assets 25.23%22.73B25.23%22.73B30.05%21.73B30.59%20.35B33.10%18.97B35.13%18.15B35.13%18.15B32.39%16.71B27.50%15.58B17.67%14.26B
Liabilities
Current liabilities
Payables 9.31%702M9.31%702M196.22%375.9M83.33%363M86.18%323.2M5.85%642.2M5.85%642.2M-0.75%126.9M55.25%198M35.80%173.6M
-accounts payable 20.07%364.9M20.07%364.9M196.22%375.9M83.33%363M86.18%323.2M55.85%303.9M55.85%303.9M-0.75%126.9M55.25%198M35.80%173.6M
-Total tax payable -19.30%99.5M-19.30%99.5M-------------41.65%123.3M-41.65%123.3M------------
-Other payable 10.51%237.6M10.51%237.6M------------7.29%215M7.29%215M------------
Current accrued expenses 29.62%2.32B29.62%2.32B28.39%2.91B22.58%2.6B35.19%2.33B41.16%1.79B41.16%1.79B42.87%2.26B42.96%2.12B12.30%1.72B
Current debt and capital lease obligation -6.38%83.7M-6.38%83.7M------------11.47%89.4M11.47%89.4M------------
-Current capital lease obligation -6.38%83.7M-6.38%83.7M------------11.47%89.4M11.47%89.4M------------
Current deferred liabilities 6.70%170.3M6.70%170.3M-------------7.05%159.6M-7.05%159.6M------------
Other current liabilities 337.12%273.2M337.12%273.2M45.05%316.2M63.80%391M31.77%377M278.79%62.5M278.79%62.5M8.24%218M5.45%238.7M0.68%286.1M
Current liabilities 29.37%3.55B29.37%3.55B37.95%3.6B31.14%3.35B38.80%3.03B28.02%2.74B28.02%2.74B36.31%2.61B39.19%2.56B12.15%2.18B
Non current liabilities
Long term debt and capital lease obligation -10.56%724.7M-10.56%724.7M-9.69%744.7M-9.41%767.6M-9.55%789.2M-8.67%810.3M-8.67%810.3M-5.95%824.6M-5.21%847.3M-2.93%872.5M
-Long term capital lease obligation -10.56%724.7M-10.56%724.7M-9.69%744.7M-9.41%767.6M-9.55%789.2M-8.67%810.3M-8.67%810.3M-5.95%824.6M-5.21%847.3M-2.93%872.5M
Other non current liabilities -15.75%196.3M-15.75%196.3M257.88%869.3M209.67%759.3M145.11%726.5M-23.18%233M-23.18%233M-18.21%242.9M-16.88%245.2M1.52%296.4M
Total non current liabilities 7.11%1.6B7.11%1.6B51.19%1.61B39.76%1.53B29.67%1.52B25.67%1.5B25.67%1.5B-9.05%1.07B-8.10%1.09B-1.84%1.17B
Total liabilities 21.51%5.15B21.51%5.15B41.79%5.21B33.72%4.88B35.62%4.54B27.18%4.24B27.18%4.24B19.07%3.68B20.61%3.65B6.84%3.35B
Shareholders'equity
Share capital 0.00%2.6M0.00%2.6M0.00%2.6M0.00%2.6M0.00%2.6M4.00%2.6M4.00%2.6M1.48%2.6M0.35%2.6M0.46%2.6M
-common stock 0.00%2.6M0.00%2.6M0.00%2.6M0.00%2.6M0.00%2.6M4.00%2.6M4.00%2.6M1.48%2.6M0.35%2.6M0.46%2.6M
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings 55.49%10.14B55.49%10.14B60.83%9.17B70.49%8.14B82.26%7.22B103.79%6.52B103.79%6.52B134.66%5.7B202.36%4.77B162.13%3.96B
Paid-in capital 0.86%7.45B0.86%7.45B1.58%7.34B3.79%7.37B4.18%7.22B7.35%7.39B7.35%7.39B1.97%7.23B-7.07%7.1B-7.59%6.93B
Gains losses not affecting retained earnings -1,887.50%-14.3M-1,887.50%-14.3M-103.07%-3M-169.22%-39.8M-215.93%-13.1M-94.97%800K-94.97%800K745.97%97.6M328.55%57.5M133.93%11.3M
Total stockholders'equity 26.36%17.58B26.36%17.58B26.73%16.51B29.64%15.47B32.32%14.43B37.75%13.91B37.75%13.91B36.71%13.03B29.76%11.93B21.46%10.91B
Total equity 26.36%17.58B26.36%17.58B26.73%16.51B29.64%15.47B32.32%14.43B37.75%13.91B37.75%13.91B36.71%13.03B29.76%11.93B21.46%10.91B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday+0.41%